tirzepatide effect on kidneys The benefits and risks of in various metabolic diseases New Cleveland Clinic research finds

But weight loss varied based on when a person stopped taking the drugs, researchers found

Abstract Importance Semaglutide and tirzepatide, the new generation of glucagon-like peptide-1 receptor agonist used to treat type 2 diabetes and obesity, were recently reported to be associated with increased risk of nonarteritic anterior ischemic optic neuropathy (NAION)

GLP-1-related hair loss typically peaks 24 months after the triggering event (usually rapid weight loss) and begins to resolve over the following 36 months

It is important to dispose of any unused semaglutide after 28 days to avoid issues related to decreased potency and ensure effective weight management

They peak during dose escalation and diminish within a few weeks of stabilizing at 15 mg

The Lab Test If unsure, simple labs help: ferritin iron vitamin D zinc B12 thyroid panel These often reveal the hidden cause behind semaglutide side effects hair loss